P04.16
Newborn affected by maternal use of amphetamines
Clinical Classification Guidelines
Medical Intelligence & Overview
ICD-10 Code P04.16 refers to newborns who are affected by the mother's use of amphetamines during pregnancy. Amphetamines are stimulant drugs that can pass from mother to baby through the placenta, potentially impacting the baby's development and health at birth. This condition highlights the importance of monitoring and managing substance use during pregnancy to reduce risks for the newborn. Recognizing the signs associated with this condition can help healthcare providers offer appropriate care and support to both mother and child.
Causes & Symptoms
Clinical Causes: Maternal consumption of amphetamines during pregnancy, including recreational use or prescription medications containing amphetamines Persistent use of illicit stimulant drugs during pregnancy Inadequate prenatal care leading to unaddressed substance use issues
Key Symptoms: Premature birth (born before 37 weeks of gestation) Low birth weight Poor feeding or difficulty feeding High-pitched or persistent crying Irritability or excessive fussiness Sleep disturbances Respiratory problems or rapid breathing Tremors or muscle twitching Increased heart rate Potential developmental delays as the child grows
Diagnostic & Treatment
Diagnosis Path: Review of maternal medical and substance use history Physical examination of the newborn for signs of withdrawal or distress Laboratory testing, including urine or meconium analysis, to detect the presence of amphetamines and their metabolites Monitoring of vital signs and growth parameters
Treatment Protocols: Supportive care in a neonatal intensive care unit (NICU) if necessary Monitoring and management of withdrawal symptoms, often through comforting measures and adjusted feeding strategies Providing a quiet, low-stimulation environment to reduce irritability Nutritional support to promote healthy growth Frequent assessments of developmental progress Post-discharge follow-up with pediatric specialists to ensure ongoing developmental support
Clinical Advice & FAQs
Billing Guidance
Is P04.16 a billable ICD-10 code?
Yes, P04.16 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report P04.16?
Clinical documentation must specify the nature of Newborn affected by maternal use of amphetamines and any associated comorbidities for accurate reporting.
Cite this Clinical Reference